Number of pages: 100-120 | Report Format: PDF | Published date: 28 January, 2020
Historical Years – 2018 & 2019 | Base Year – 2020 | Forecasted Years – 2021 to 2031
Market Fundamentals
Cardiac safety services help in designing and supporting the clinical trials or other studies that require monitoring of cardiac safety. The cardiac safety services focus on monitoring of entire cardiac safety profile from Phase I to IV for the given study compound in compliance with ICH, EMA, FDA, PMDA, and other regulatory authorities and industry guidelines. Cardiac safety services include ECG/Holter measurement, cardiovascular imaging, blood pressure measurement, thorough QT studies and other services.
[98463342]
Market Dynamics
The global cardiac safety services market is mainly driven by increasing number of clinical trials, and growing R&D activities in pharmaceuticals and biopharmaceutical companies. Technological advancements in healthcare industry and growing developments in the biosimilars & biologics are also playing a pivotal role in contributing to the market growth globally. However, high cost of cardiac safety evaluation is likely to restrain the market growth to a certain extent.
Market Ecosystem
The global cardiac safety services market has been analyzed from four perspectives: Type, Services, End User, and Region.
Cardiac Safety Services Market by Type
[52232323]
Based on type, the market has been segmented into standalone and integrated. The integrated segment is expected to hold highest share during the forecast period owing to its advantages of bundled services to oversee end-to-end developments as compared to the specificity of standalone services.
Cardiac Safety Services Market by Services
Based on services, the market has been segmented into cardiac imaging, ECG/holter measurement, blood pressure measurement, thorough QT study and other services. ECG/holter measurement services segment is expected to hold highest share during the forecast period. The growth of the segment in the global market can be largely attributed to its low cost and their wide usage in measuring cardiac activity.
Cardiac Safety Services Market by End User
Based on end user, the cardiac safety services market has been segmented into pharmaceutical companies, contract research organizations (CROs) and others. Contract Research Organizations (CROs) segment is expected to be the fastest-growing market for cardiac safety services and is anticipated to contribute significantly to the global market share during the forecast period. The growth of the segment can mainly be attributed to the increasing number of clinical trials and increased outsourcing of R&D activities.
Cardiac Safety Services Market by Region
Based on region, the global cardiac safety services market has been segmented into North America, Europe, Asia Pacific, and the Rest of the World (ROW). North America dominated the cardiac safety services market, followed by Europe. The large share of North America in the global market can be attributed to presence of major pharmaceutical & biopharmaceutical companies, increase in investments in R&D activities, and rise in the prevalence of cardiovascular diseases in the region.
Competitive Landscape
Some of the prominent players operating in the cardiac safety services market includes:-
Strategic Developments
Report Attribute |
Details |
Revenue forecast in 2031 |
USD ~1540 million |
Market size value in 2020 |
USD ~488 billion |
Growth Rate |
CAGR of ~11.0% from 2021 to 2031 |
Base year for estimation |
2020 |
Forecast period |
2021-2031 |
Segments covered |
Type, Services, End User |
Regional scope |
North America, Europe, Asia Pacific, and the Rest of the World (ROW) |
arrow_forward The global cardiac safety services Market was anticipated to clock US$ ~488 Million in 2020
arrow_forward The cardiac safety services market is projected to reach US$ ~1540 million by 2031
arrow_forward The global cardiac safety services market is mainly driven by increasing number of clinical trials, and growing R&D activities in pharmaceuticals and biopharmaceutical companies.
arrow_forward Medpace, Inc, Celerion, Biotrial, IQVIA, ERT Clinical, BioTelemetry, Inc, Laboratory Corporation of America® Holdings, Bioclinica, Ncardia, Richmond Pharmacology
arrow_forward The growth rate of cardiac safety services market is CAGR of ~11.0% between 2021-2031
arrow_forward North America held the largest share of the global cardiac safety services market in 2020
*Insights on financial performance is subject to availability of information in public domain
Growth+Reports can now be customized as per client’s needs through GRG Health’s primary research and knowledge services capabilities
GRG Health’s unique GrowthMIX approach and robust research methodology helps us deliver unique & meaningful insights to our clients and uncover trends that won’t meet the standard approach